Photo by atikahakhtar from unsplash
It mostly affects end‐stage renal disease patients on dialysis. Incidence is in the range of 1:1000 to 1:1500 cases in patients on chronic renal replacement therapy.3 Exceptions have been reported… Click to show full abstract
It mostly affects end‐stage renal disease patients on dialysis. Incidence is in the range of 1:1000 to 1:1500 cases in patients on chronic renal replacement therapy.3 Exceptions have been reported in patients with normal renal function and in association with chronic inflammatory disease, malignancy or primary hyperparathyroidism. Secondary infection of necrotic skin lesions and subsequent sepsis can cause high mortality of up to 80%.
Keywords:
hyperparathyroidism;
marker hyperparathyroidism;
calciphylaxis cutaneous;
cutaneous marker;
therapy;
hyperparathyroidism successful
Journal Title: Indian Journal of Dermatology, Venereology and Leprology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Indian Journal of Dermatology, Venereology and Leprology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!